BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37703493)

  • 1. Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 to 18 F-FDG PET/CT in a Case of SMARCA4-Deficient Undifferentiated Carcinoma of Stomach.
    Pang Y; Cai J; Zhao L; Xu W; Chen H
    Clin Nucl Med; 2023 Nov; 48(11):1009-1011. PubMed ID: 37703493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of [
    Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
    Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68 Ga-DOTA-FAPI-04 PET/CT in the Detection of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
    Shen X; Yang Z; Li N
    Clin Nucl Med; 2023 Dec; 48(12):1102-1104. PubMed ID: 37846457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
    Guo J; Liao Z; Chen Q; Dong A; Huang M
    Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate preoperative staging with [
    Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
    Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [
    Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [
    Chen H; Pang Y; Li J; Kang F; Xu W; Meng T; Shang Q; Zhao J; Guan Y; Wu H; Xie F; Wang J; Sun L
    Eur Radiol; 2023 Feb; 33(2):1329-1341. PubMed ID: 35976396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging.
    Kaplan İ; Can C; Kepenek F; Ibiloğlu İ; Güzel Y
    Clin Nucl Med; 2023 Jun; 48(6):e307-e309. PubMed ID: 36754357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [
    Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher accuracy of [
    Zhou X; Wang S; Xu X; Meng X; Zhang H; Zhang A; Song Y; Zhu H; Yang Z; Li N
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2983-2993. PubMed ID: 35543731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.